Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.
Gaudio F, Giordano A, Pavone V, Perrone T, Curci P, Pastore D, Delia M, De' Risi C, Spina A, Liso V, Specchia G. Gaudio F, et al. Among authors: perrone t. Adv Hematol. 2011;2011:707542. doi: 10.1155/2011/707542. Epub 2010 Dec 29. Adv Hematol. 2011. PMID: 21253449 Free PMC article.
Primary intracranial dural B cell small lymphocytic lymphoma.
Giordano A, Perrone T, Guarini A, Ciappetta P, Rubini G, Ricco R, Palma M, Specchia G, Liso V. Giordano A, et al. Among authors: perrone t. Leuk Lymphoma. 2007 Jul;48(7):1437-43. doi: 10.1080/10428190701387021. Leuk Lymphoma. 2007. PMID: 17613779 Review. No abstract available.
CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
Pastore D, Delia M, Mestice A, Carluccio P, Perrone T, Gaudio F, Curci P, Rossi AR, Ricco A, Specchia G. Pastore D, et al. Among authors: perrone t. Biol Blood Marrow Transplant. 2012 Jun;18(6):887-93. doi: 10.1016/j.bbmt.2011.10.039. Epub 2011 Nov 4. Biol Blood Marrow Transplant. 2012. PMID: 22062803 Free article.
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.
Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, Boccomini C, Genuardi E, Chiappella A, Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto A, Galimberti S, Bari A, Rota-Scalabrini D, Ferrari A, Zaja F, Gallamini A, Specchia G, Musto P, Rossi FG, Gamba E, Evangelista A, Vitolo U; Fondazione Italiana Linfomi. Ladetto M, et al. Blood. 2013 Nov 28;122(23):3759-66. doi: 10.1182/blood-2013-06-507319. Epub 2013 Oct 1. Blood. 2013. PMID: 24085766 Free article. Clinical Trial.
187 results